The febrile infant: New AAP guidance for the first 2 months of life
July 19, 2021
The recommendations were derived from interpretations of sequential studies in young, febrile, but well-appearing infants.
C. difficile guidelines offer new possibilities
June 24, 2021
Updated recommendations address issues of diagnosis, recurrence, and fecal microbial transplant.
CDC: New botulism guidelines focus on mass casualty events
June 2, 2021
The new guidance “was really specific [and] was meant to address the gap in guidance for mass casualty settings.”
New AHA/ASA guideline on secondary stroke prevention
May 27, 2021
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in an updated clinical practice guideline.
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
May 24, 2021
As CDC investigates rare, mostly mild cases of myocarditis in adolescents and young adults given the Pfizer or Moderna vaccine, AHA emphasizes their effectiveness and strong safety record.
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
March 16, 2021
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured properly.”
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
March 11, 2021
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
January 12, 2021
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for chronic conditions.
Updated ACC decision pathway embraces new heart failure treatment strategies
January 11, 2021
The ACC’s updated decision pathway aims to close the substantial gap between current practice and unmet opportunities for inhibiting HFrEF progression.
ACC/AHA update two atrial fibrillation performance measures
December 14, 2020
The changes clarify the definition of atrial fibrillation and separate CHA2DS2-VASc risk score treatment thresholds for men and women; both are in line with 2019 guideline changes.